Easing the Burden of Treatment: Novel Approaches to Cancer Immunotherapy

Cancer immunology is one of the most exciting and important areas of investigation in cancer research today. Dana-Farber Cancer Institute has a long history of excellence in this field and our immunology investigators have made significant contributions to advances that are now benefiting cancer patients. Listen to this conversation led by Chief Scientific Officer Kevin Haigis, PhD, and featuring Stephanie Dougan, PhD, and Eric Smith, MD, PhD, to learn about the latest research surrounding cancer immunotherapies.

To learn more, visit the Revolutionary Science section of this site.

Give Now

Thank you for your interest in learning more about The Dana-Farber Campaign. You have been added to our email list and will receive updates on ways to join us in defying cancer. You can unsubscribe at any time.

There has been an issue submitting your request. Please try again.

Founded in Boston in 1947, Dana-Farber is a principal teaching affiliate of Harvard Medical School and a federally designated Comprehensive Cancer Center that develops and disseminates innovative patient therapies and scientific discoveries throughout the world. About Our Patient Stories: Dana-Farber shares patient stories which may include descriptions of actual medical results. Dana-Farber provides personalized care for each patient based on their unique needs; their experiences and results will vary.

At Dana-Farber we are committed to an inclusive community where human differences are valued and celebrated, and where all are welcome. We work every day to create an innovative, caring, and inclusive environment where each patient, family, and staff member feels valued and respected.